As of 2026-01-24, the Intrinsic Value of Mustang Bio Inc (MBIO) is -2.90 USD. This MBIO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.07 USD, the upside of Mustang Bio Inc is -371.34%.
Based on its market price of 1.07 USD and our intrinsic valuation, Mustang Bio Inc (MBIO) is overvalued by 371.34%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.90 - -2.90 | -2.90 | -371.34% |
| P/E | (6.94) - (7.94) | (7.97) | -845.1% |
| DDM - Stable | (3.32) - (16.41) | (9.86) | -1021.8% |
| DDM - Multi | (21.86) - (84.98) | (34.88) | -3360.1% |
| Market Cap (mil) | 7.81 |
| Beta | 0.73 |
| Outstanding shares (mil) | 7.30 |
| Enterprise Value (mil) | -11.17 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.25% |
| Cost of Debt | 5.00% |
| WACC | 5.96% |